Vantictumab Biosimilar (FZD Reference Antibody)
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Product Specifications
Target
Vantictumab Biosimilar (Anti-FZD Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
313102 300 Pack (30 Sleeve (s) x 10 Wand)
SCN-10-2 ClipSleeve Markers
Sign In for Pricing
View Details MR200945L3V 200 µL
Ang4 (NM_177544) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
